KromaTiD

Developer of next-gen cytogenetic products focused on discovering, detecting, and diagnosing genomic rearrangements in the areas of oncology and rare diseases. The company's molecular cytogenetic and ...

Healthcare

Longmont, CO, United States

Founded 2007

35 employees

Website

Valuation

$39M

Market implied

Share Price

N/A

Total Raised

$23.6M

Last Round

N/A

Investors

+10 other investors

View all 10 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock KromaTiD's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required